Key result
H-FABP shows high diagnostic accuracy for acute MI at admission with an AUC of ~0.89.
Cross-Sectional (n=113)
No
Cardiac biomarkers play a vital role in diagnosing and differentiating myocardial ischemia and acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
May support early AMI and ischemia diagnosis; hypothesis-generating and should not yet change practice.
Introduction: Myocardial ischemia and acute myocardial infarction are important episodes of cardiac ailments. Cardiac biomarkers are a growing area of interest, constantly evolving and presenting potential promises diagnostically to supplement the instrumental techniques. They play a vital role in every stage of sequel of cardiac ailment by contributing to the diagnosis and differentiating the conditions.
No takes yet. Share an insight, caveat, or question.
Munta et al. (2018) conducted a cross-sectional in Myocardial Ischemia and Acute Myocardial Infarction (n=113). Serum cardiac biomarkers (H-FABP, NTproBNP, hscTnI, IMA) vs. Healthy controls was evaluated on Diagnostic accuracy (Area Under the Curve) of H-FABP for acute myocardial infarction at admission (AUC 0.89, 95% CI 0.72-0.92). Heart-type fatty acid binding protein demonstrated the highest diagnostic accuracy for acute myocardial infarction at admission, while NTproBNP was most accurate for myocardial ischemia.
Synapse has enriched 10 related papers. Consider them for comparative context: